1. IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

   • Tania Benatar
   • Ming Y. Cao
   • Aiping H. Young

   Original Article 13 December 2009 Pages: 805 - 817

   

2. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment

   • Thaís Helena Gasparoto
   • Tatiana Salles de Souza Malaspina
   • Ana Paula Campanelli

   Original Article 12 December 2009 Pages: 819 - 828

   

3. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked

   • Marie von Lilienfeld-Toal
   • Susanne Frank
   • Gordon Cook

   Original Article 19 December 2009 Pages: 829 - 839

   

4. Circulating tumour-derived microvesicles in plasma of gastric cancer patients

   • Jaroslaw Baran
   • Monika Baj-Krzyworzeka
   • Marek Zembala

   Original Article 31 December 2009 Pages: 841 - 850

   

5. CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting

   • Håkan Norell
   • Yi Zhang
   • Michael I. Nishimura

   Original Article 06 January 2010 Pages: 851 - 862

   

6. Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine

   • Adam Dangoor
   • Paul Lorigan
   • Robert Hawkins

   Original Article 31 December 2009 Pages: 863 - 873

   

7. Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity

   • Norimasa Matsushita
   • Hiroshi Komine
   • James J. Mulé

   Original Article 08 January 2010 Pages: 875 - 884

   

8. Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity

   • Hong Lin
   • Elisa de Stanchina
   • Susanna Cunningham-Rundles

   Original Article 06 February 2010 Pages: 885 - 897

   

9. Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice

   • Bohan Dong
   • Luguo Sun
   • Liying Wang

   Original Article 20 January 2010 Pages: 899 - 908

   

10. Foxp3⁺ cell infiltration and granzyme B⁺/Foxp3⁺ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma

    • Martin Pölcher
    • Michael Braun
    • Juan-José Hernando

    Original Article 20 January 2010 Pages: 909 - 919

    

11. Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells

    • Nadine Pouw
    • Elike Treffers-Westerlaken
    • Reno Debets

    Original Article 26 January 2010 Pages: 921 - 931

    

12. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro

    • Yinting Chen
    • Kaihong Huang
    • Ying Wu

    Original Article 12 March 2010 Pages: 933 - 942

    

13. HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase

    • Brian M. Olson
    • Thomas P. Frye
    • Douglas G. McNeel

    Original Article 06 February 2010 Pages: 943 - 953

    

14. “Tumor immunology meets oncology IV”, 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany

    • Juergen Bukur
    • Dennis Loeffler
    • Barbara Seliger

    Meeting Report 28 August 2008 Pages: 955 - 962

15. Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008

    • Michele Maio
    • Hugues J. M. Nicolay
    • for the NIBIT

    Meeting Report 28 March 2009 Pages: 963 - 969

16. The second cellular therapy of cancer symposium, 27–29 March 2009, Milan, Italy

    • John S. Bridgeman
    • David E. Gilham
    • Eleanor J. Cheadle

    Meeting Report 08 August 2009 Pages: 971 - 974

17. Acknowledgement

    ACKNOWLEDGEMENT TO REVIEWERS 03 March 2010 Pages: 975 - 978